The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Oxidative Stress and Diabetic Complications
Open accessAbstract
Oxidative stress plays a pivotal role in the development of diabetes complications, both microvascular and cardiovascular. The metabolic abnormalities of diabetes cause mitochondrial superoxide overproduction in endothelial cells of both large and small vessels, as well as in the myocardium. This increased superoxide production causes the activation of 5 major pathways involved in the pathogenesis of complications: polyol pathway flux, increased formation of AGEs (advanced glycation end products), increased expression of the receptor for AGEs and its activating ligands, activation of protein kinase C isoforms, and overactivity of the hexosamine pathway. It also directly inactivates 2 critical antiatherosclerotic enzymes, endothelial nitric oxide synthase and prostacyclin synthase. Through these pathways, increased intracellular reactive oxygen species (ROS) cause defective angiogenesis in response to ischemia, activate a number of proinflammatory pathways, and cause long-lasting epigenetic changes that drive persistent expression of proinflammatory genes after glycemia is normalized (“hyperglycemic memory”). Atherosclerosis and cardiomyopathy in type 2 diabetes are caused in part by pathway-selective insulin resistance, which increases mitochondrial ROS production from free fatty acids and by inactivation of antiatherosclerosis enzymes by ROS. Overexpression of superoxide dismutase in transgenic diabetic mice prevents diabetic retinopathy, nephropathy, and cardiomyopathy. The aim of this review is to highlight advances in understanding the role of metabolite-generated ROS in the development of diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chronic overproduction of ROS increases oxidative stress, damages DNA, increases apoptosis, and triggers inflammation, which is a key feature in T2DM and metabolic syndrome (42).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Taken together, our data suggest significant molecular and metabolic perturbations between NHOs and PGDHOs consistent with previous studies on PGD suggesting increased oxidative stress, cardiomyopathy, and altered lipid profiles48–50”
From Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease (2021) · cites this paper as [49]
In the citing paper
“Hyperglycemia and PKC activation-induced ROS production result in inflammatory changes in the vascular endothelium including monocytes adhesion, formation of foam cells, and activation of major biochemical paths including polyol pathway flux and increased formation of advanced glycation end products, further contributing to the development of atherosclerosis.40”
From Glycemic variability and cardiovascular disease in patients with type 2 diabetes (2021) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Xie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M. (2008) · Diabetes · doi:10.2337/db08-0610 · Cited by 165
RetractedReddy, M. A., Villeneuve, L. M., Wang, M., Lanting, L. L., & Natarajan, R. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.175190 · Cited by 83
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases, NIH; 1995.
Cited by
Sorted by citations
Items 301–400 of 1,018
CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress
Hua, W., Huang, H., Tan, L.-T., Wan, J., Gui, H.-B., Zhao, L., Ruan, X. Z., Chen, X., & Du, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127507 · Cited by 163
Stefano, G. B., Challenger, S., & Kream, R. M. (2016) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/s00394-016-1212-2 · Cited by 164
Antioxidant Therapy and Antioxidant-Related Bionanomaterials in Diabetic Wound Healing
Zhang, W., Chen, L., Xiong, Y., Panayi, A. C., Abududilibaier, A., Hu, Y., Yu, C., Zhou, W., Sun, Y., Liu, M., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.707479 · Cited by 169
Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases
Saxena, P., Selvaraj, K., Khare, S. K., & Chaudhary, N. (2021) · Biotechnology Letters · doi:10.1007/s10529-021-03200-3 · Cited by 170
Role of Oxidative Stress in Diabetic Cardiomyopathy
Geest, B. D., & Mishra, M. (2022) · Antioxidants · doi:10.3390/antiox11040784 · Cited by 172
Reversibility of Structural and Functional Damage in a Model of Advanced Diabetic Nephropathy
Pichaiwong, W., Hudkins, K. L., Wietecha, T., Nguyen, T. Q., Tachaudomdach, C., Li, W., Askari, B., Kobayashi, T., O’Brien, K. D., Pippin, J. W., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050445 · Cited by 162
Periyasamy, P., & Shinohara, T. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.08.003 · Cited by 164
Tabrizi, R., Vakili, S., Akbari, M., Mirhosseini, N. Z., Lankarani, K. B., Rahimi, M., Mobini, M., Jafarnejad, S., Vahedpoor, Z., & Asemi, Z. (2018) · Phytotherapy Research · doi:10.1002/ptr.6226 · Cited by 161
Metabolic memory: mechanisms and diseases
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., Leung, W. K., & Wang, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01755-x · Cited by 186
Obesity-Related Oxidative Stress: the Impact of Physical Activity and Diet Manipulation
Huang, C., McAllister, M. J., Slusher, A. L., Webb, H. E., Mock, J. T., & Acevedo, E. O. (2015) · Sports Medicine - Open · doi:10.1186/s40798-015-0031-y · Cited by 166
Vascular endothelium dysfunction: a conservative target in metabolic disorders
Jamwal, S., & Sharma, S. (2018) · Inflammation Research · doi:10.1007/s00011-018-1129-8 · Cited by 161
Insulin Resistance, Diabetes, and Cardiovascular Risk
Paneni, F., Costantino, S., & Cosentino, F. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0419-z · Cited by 162
Implication of oxidative stress in progression of diabetic retinopathy
Behl, T., Kaur, I., & Kotwani, A. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.06.001 · Cited by 160
Roles of O-GlcNAc in chronic diseases of aging
Banerjee, P. S., Lagerlöf, O., & Hart, G. W. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.05.005 · Cited by 165
Maternal Factors that Induce Epigenetic Changes Contribute to Neurological Disorders in Offspring
Banik, A., Kandilya, D., Ramya, S., Stünkel, W., Chong, Y. S., & Dheen, S. T. (2017) · Genes · doi:10.3390/genes8060150 · Cited by 163
Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review
Roohbakhsh, A., Karimi, G., & Iranshahi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.057 · Cited by 156
Hsieh, C., Liu, C., Lee, C., Yu, L.-E., & Wang, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37215-0 · Cited by 159
Ebrahimpour, S., Zakeri, M., & Esmaeili, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101095 · Cited by 163
Kumar, P., Liu, C., Suliburk, J. W., Hsu, J. W.-C., Muthupillai, R., Jahoor, F., Minard, C. G., Taffet, G. E., & Sekhar, R. V. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac135 · Cited by 170
Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D. (2012) · Diabetes · doi:10.2337/db12-0224 · Cited by 155
Glycemic variability and cardiovascular disease in patients with type 2 diabetes
Martinez, M., Santamarina, J., Pavesi, A., Musso, C., & Umpierrez, G. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002032 · Cited by 155
Madonna, R., & Caterina, R. D. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.005 · Cited by 157
Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes
Ghosh, P., Sahoo, R., Vaidya, A., Chorev, M., & Halperin, J. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1099 · Cited by 160
Bhatt, M. P., Lim, Y., Kim, Y., & Ha, K. (2013) · Diabetes · doi:10.2337/db13-0039 · Cited by 158
Rad, S. K., Arya, A., Karimian, H., Madhavan, P., Rizwan, F., Koshy, S., & Prabhu, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s173970 · Cited by 167
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
Grisanti, L. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01669 · Cited by 160
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Thakur, S., Gupta, S. K., Ali, V., Singh, P., & Verma, M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01343-5 · Cited by 159
An update on advanced glycation endproducts and atherosclerosis
Turco, S. D., & Basta, G. (2012) · BioFactors · doi:10.1002/biof.1018 · Cited by 157
Effect of diet-derived advanced glycation end products on inflammation
Kellow, N. J., & Coughlan, M. T. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv030 · Cited by 160
Shah, A., Xia, L., Goldberg, H. J., Lee, K. W., Quaggin, S. E., & Fantus, I. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419101 · Cited by 152
Santhakumar, A. B., Bulmer, A. C., & Singh, I. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12177 · Cited by 159
miR-195 regulates SIRT1-mediated changes in diabetic retinopathy
Mortuza, R., Feng, B., & Chakrabarti, S. (2014) · Diabetologia · doi:10.1007/s00125-014-3197-9 · Cited by 153
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Horváth, B., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.003 · Cited by 152
Engineered delivery strategies for enhanced control of growth factor activities in wound healing
Niu, Y., Li, Q., Ding, Y., Dong, L., & Wang, C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.002 · Cited by 155
Aureliano, M., Sousa‐Coelho, A. L. D., Dolan, C. C., Roess, D. A., & Crans, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065382 · Cited by 161
Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications
Ranasinghe, P. D., Pigera, S., Galappatthy, P., Katulanda, P., & Constantine, G. R. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0127-4 · Cited by 155
Guo, Y., Zhuang, X., Huang, Z., Zou, J., Yang, D.-Y. D., Hu, X., Du, Z., Wang, L., & Liao, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.029 · Cited by 152
Vascular Stiffness in Aging and Disease
Vatner, S. F., Zhang, J., Vyzas, C., Mishra, K., Graham, R. M., & Vatner, D. E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.762437 · Cited by 152
CaMKII oxidative activation and the pathogenesis of cardiac disease
Luczak, E. D., & Anderson, M. E. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.004 · Cited by 157
Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats
Moneim, A. E. A., Al‐Quraishy, S., & Dkhil, M. A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91377 · Cited by 151
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
Berlanga‐Acosta, J., Schultz, G. S., López‐Mola, E., Guillén, G. E., García-Siverio, M., & Herrera-Martínez, L. (2012) · BioMed Research International · doi:10.1155/2013/256043 · Cited by 158
Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology
Olvera-Montaño, C., Alberto, C.-G. J., Navarro‐Partida, J., Cardona-Muñóz, E. G., López-Contreras, A. K., Román-Pintos, L. M., Robles-Rivera, R. R., & Rodríguez-Carrizález, A. D. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8562408 · Cited by 159
Hydroxycinnamic acids and human health: recent advances
Coman, V., & Vodnar, D. C. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10010 · Cited by 158
Lee, J., Yun, J., & Ko, S. (2022) · Nutrients · doi:10.3390/nu14153086 · Cited by 161
Glutathione Participation in the Prevention of Cardiovascular Diseases
Matuz‐Mares, D., Riveros‐Rosas, H., Vilchis‐Landeros, M. M., & Vázquez‐Meza, H. (2021) · Antioxidants · doi:10.3390/antiox10081220 · Cited by 152
Teodoro, J. S., Nunes, S., Rolo, A. P., Reis, F., & Palmeira, C. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01857 · Cited by 150
Coletta, C., Módis, K., Szczęsny, B., Brunyánszki, A., Oláh, G., Rios, E. C. S., Yanagi, K., Ahmad, A., Papapetropoulos, A., & Szabó, C. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00035 · Cited by 147
The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
Bhakkiyalakshmi, E., Sireesh, D., Rajaguru, P., Paulmurugan, R., & Ramkumar, K. M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.004 · Cited by 149
Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review
Junren, C., Xiaofang, X., Huiqiong, Z., Li, G., Yanpeng, Y., Xiaoyu, C., Gao, Y., Li, Y., Zhang, Y., Fu, P., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.660757 · Cited by 159
Polyol pathway and redox balance in diabetes
Garg, S. S., & Gupta, J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106326 · Cited by 158
Advanced Glycation End Products in Health and Disease
Reddy, V. P., Aryal, P., & Darkwah, E. K. (2022) · Microorganisms · doi:10.3390/microorganisms10091848 · Cited by 155
Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future
Iacobini, C., Vitale, M., Pesce, C. M., Pugliese, G., & Menini, S. (2021) · Antioxidants · doi:10.3390/antiox10050727 · Cited by 161
Huo, J., Feng, Q., Pan, S., Fu, W.-J., Liu, Z., & Liu, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01553-4 · Cited by 148
Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications
Landon, R., Gueguen, V., Petite, H., Letourneur, D., Pavon‐Djavid, G., & Anagnostou, F. (2020) · Marine Drugs · doi:10.3390/md18070357 · Cited by 146
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Góra, I. M., Ciechanowska, A., & Ładyżyński, P. (2021) · Cells · doi:10.3390/cells10020314 · Cited by 159
Emerging Theranostic Nanomaterials in Diabetes and Its Complications
Liu, Y., Zeng, S., Ji, W., Yao, H., Lin, L., Cui, H., Santos, H. A., & Pan, G. (2021) · Advanced Science · doi:10.1002/advs.202102466 · Cited by 142
The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus.
Zatalia, S. R., & Sanusi, H. (2013) · PubMed · Cited by 142
Dowey, R., Iqbal, A., Heller, S. R., Sabroe, I., & Prince, L. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678771 · Cited by 144
Caturano, A., Rocco, M. P., Tagliaferri, G., Piacevole, A., Nilo, D., Lorenzo, G. D., Iadicicco, I., Donnarumma, M., Galiero, R., Acierno, C., et al. (2025) · Antioxidants · doi:10.3390/antiox14010072 · Cited by 178
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy
Wilkinson‐Berka, J. L., Rana, I., Armani, R., & Agrotis, A. (2013) · Clinical Science · doi:10.1042/cs20120212 · Cited by 141
Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus
Banerjee, M., & Vats, P. (2013) · Redox Biology · doi:10.1016/j.redox.2013.12.001 · Cited by 150
Padiya, R., Chowdhury, D., Borkar, R. M., Srinivas, R., Bhadra, M. P., & Banerjee, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094228 · Cited by 140
Salminen, A., Kauppinen, A., Hiltunen, M. O., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.05.004 · Cited by 145
Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats
Saito, S., Teshima, Y., Fukui, A., Kondo, H., Nishio, S., Nakagawa, M., Saikawa, T., & Takahashi, N. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu176 · Cited by 145
Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
Peiró, C., Romacho, T., Azcutia, V., Villalobos, L. A., Fernández, E., Bolaños, J. P., Moncada, S., & Sánchez‐Ferrer, C. F. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0397-2 · Cited by 147
Prasad, S., Sajja, R. K., Kaisar, M. A., Park, J. H., Villalba, H., Liles, T., Abbruscato, T. J., & Cucullo, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.007 · Cited by 138
Ohlsson, B., Orho‐Melander, M., & Nilsson, P. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030582 · Cited by 140
Sinclair, S. H., & Schwartz, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00843 · Cited by 153
Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction
Lassén, E., & Daehn, I. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249456 · Cited by 145
Xiong, Y., Knoedler, S. A., Alfertshofer, M. G., Kim, B., Jiang, D., Liu, G., Rinkevich, Y., & Mi, B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07583-3 · Cited by 157
Gülçın, İ., Gören, A. C., Taslımı, P., Alwasel, S. H., Kılıç, Ö., & Bursal, E. (2019) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2019.101441 · Cited by 139
Nanoceria, the versatile nanoparticles: Promising biomedical applications
Saifi, M. A., Seal, S., & Godugu, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.033 · Cited by 139
Gurunathan, S., Pratheep, T., & Kim, J. (2023) · Foods · doi:10.3390/foods13010089 · Cited by 159
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Spahis, S., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 142
Nanozymes for regulation of reactive oxygen species and disease therapy
Dai, Y., Ding, Y., & Li, L. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.03.036 · Cited by 142
Vascular complications of diabetes: A narrative review
Lu, Y., Wang, W., Liu, J., Xie, M., Liu, Q., & Li, S. (2023) · Medicine · doi:10.1097/md.0000000000035285 · Cited by 171
Reactive aldehydes – second messengers of free radicals in diabetes mellitus
Jaganjac, M., Tirosh, O., Cohen, G., Sasson, S., & Žarković, N. (2013) · Free Radical Research · doi:10.3109/10715762.2013.789136 · Cited by 137
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
Fisher, V. L., & Tahrani, A. A. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s129797 · Cited by 145
Epigenetics in the pathogenesis of diabetic nephropathy
Li, X., Lu, L., Hou, W., Huang, T., Chen, X., Qi, J., Zhao, Y., & Zhu, M. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021016 · Cited by 143
Anti-Inflammatory Therapy for Diabetic Retinopathy
Zhang, W., Liu, H., Rojas, M., Caldwell, R. W., & Caldwell, R. B. (2011) · Immunotherapy · doi:10.2217/imt.11.24 · Cited by 137
Psychological aspects of diabetes care: Effecting behavioral change in patients
Chew, B. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.796 · Cited by 157
Teixeira‐Lemos, E., de Oliveira, J. B. F., Pinheiro, J. P., & Reis, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/741545 · Cited by 136
Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes
Fukushima, A., & Lopaschuk, G. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.020 · Cited by 140
Autophagy in Diabetic Retinopathy
Rosa, M. D., Distefano, G., Gagliano, C., Rusciano, D., & Malaguarnera, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160321122900 · Cited by 137
Koska, J., Saremi, A., Howell, S., Bahn, G., De Courten, B., Ginsberg, H., Beisswenger, P. J., Reaven, P. D., & for the VADT Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1740 · Cited by 134
A Ligand-Independent VEGFR2 Signaling Pathway Limits Angiogenic Responses in Diabetes
Warren, C. M., Ziyad, S., Briot, A., Der, A., & Iruela‐Arispe, M. L. (2014) · Science Signaling · doi:10.1126/scisignal.2004235 · Cited by 138
Hsu, Y.-Y., Tseng, Y., & Lo, Y. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.008 · Cited by 134
Olsen, A. S., Sarras, M. P., Leontovich, A. A., & Intine, R. V. A. (2012) · Diabetes · doi:10.2337/db11-0588 · Cited by 136
The Nrf2 pathway in the progression of renal disease
Zoja, C., Benigni, A., & Remuzzi, G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft224 · Cited by 135
Verma, S., Singh, P., Khurana, S., Ganguly, N. K., Kukreti, R., Saso, L., Rana, D. S., Taneja, V., & Bhargava, V. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.163 · Cited by 136
Lei, H., & Fan, D. (2022) · Advanced Science · doi:10.1002/advs.202201425 · Cited by 134
Therapeutic role of growth factors in treating diabetic wound
Zheng, S.-Y., Wan, X.-X., Kambey, P. A., Luo, Y., Hu, X., Liu, Y., Shan, J.-Q., Chen, Y., & Xiong, K. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i4.364 · Cited by 147
Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Gorin, Y. C., & Block, K. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.014 · Cited by 136
Basha, R. H., & Sankaranarayanan, C. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.12.019 · Cited by 133
Caporali, A., Meloni, M., Nailor, A., Mitić, T., Shantikumar, S., Riu, F., Sala‐Newby, G. B., Rose, L., Besnier, M., Katare, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9024 · Cited by 136
Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis
Hulsmans, M., Dooren, E. V., & Holvoet, P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0237-0 · Cited by 132
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 145
Nephroprotective Effects of Metformin in Diabetic Nephropathy
Ravindran, S., Kuruvilla, V. M., Wilbur, K., & Munusamy, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25598 · Cited by 135
Dworzański, J., Strycharz-Dudziak, M., Kliszczewska, E., Kiełczykowska, M., Dworzańska, A., Drop, B., & Polz‐Dacewicz, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230374 · Cited by 142
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
Luis-Rodríguez, D. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.7 · Cited by 132
Metadata
- Authors
- Giacco, F., & Brownlee, M.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Brownlee, Michael
- Venue
- Circulation Research
- Published
- 2010-10-29
- Volume
- 107
- Issue
- 9
- Pages
- 1058-1070
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC2996922
- OpenAlex
- W2105731956
- Cited by
- 5,461
- References
- 152
- Citations by year
- 2026: 305 · 2025: 331 · 2024: 416 · 2023: 448 · 2022: 478 · 2021: 435 · 2020: 411 · 2019: 349 · 2018: 370 · 2017: 367 · 2016: 338 · 2015: 318 · 2014: 327 · 2013: 260 · 2012: 203
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074153, R01-DK07453, P60DK020541)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, diabetes complications, superoxide, reactive oxygen species, mitochondrial dysfunction, polyol pathway, advanced glycation end products, AGE receptor, protein kinase C, hexosamine biosynthetic pathway, endothelial nitric oxide synthase, prostacyclin synthase, angiogenesis, inflammation, epigenetic modifications, atherosclerosis, diabetic cardiomyopathy, type 2 diabetes, insulin resistance, superoxide dismutase, diabetic retinopathy, diabetic nephropathy
- MeSH terms
- Animals, Humans, Hyperglycemia, Cardiomyopathies, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Diabetes Complications, Atherosclerosis, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review